Drug shortage
Naltrexone Hydrochloride Tablet · Elite Laboratories, Inc.
FDA drug shortage · Resolved · updated Feb 11, 2026
Key facts
| Generic name | Naltrexone Hydrochloride Tablet |
|---|---|
| Company | Elite Laboratories, Inc. |
| Presentation | Naltrexone Hydrochloride, Tablet, 50 mg (NDC 68094-909-50) |
| Dosage form | Tablet |
| Status | Resolved |
| Therapeutic category | Analgesia/Addiction |
| Package NDCs | 68094-909-50 |
| First posted | Feb 29, 2024 |
| Last updated | Feb 11, 2026 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: